HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

miR-146a targeted to splenic macrophages prevents sepsis-induced multiple organ injury.

Abstract
Development of a novel agent against life-threatening sepsis requires the in-depth understanding of the relevant pathophysiology and therapeutic targets. Given the function of microRNAs (miRNAs) as potent oligonucleotide therapeutics, here we investigated the pathophysiological role of exogenously applied miRNA in sepsis-induced multiple organ injury. In vitro, miR-16, miR-126, miR-146a, and miR-200b suppressed the production of pro-inflammatory cytokines in RAW264.7 macrophage cells after lipopolysaccharide (LPS) stimulation. Of these, miR-146a displayed the most highly suppressive effect, wherein the transcriptional activity of nuclear factor kappa B (NF-κB) was decreased via targeting of interleukin 1 receptor-associated kinase 1 and tumor necrosis receptor-associated factor 6. Sepsis was induced in mice via cecal ligation and puncture (CLP) and an intravenous injection of a complex of miR-146a-expressing plasmid and polyethyleneimine. Treatment with this complex significantly decreased the level of serum inflammatory cytokines, attenuated organ injury including kidney injury, and led to increased survival from polymicrobial sepsis induced by CLP. miR-146a-expressing plasmid was abundantly distributed in splenic macrophages, but not in renal parenchymal cells. CLP mice treated with miR-146a displayed significantly decreased NF-κB activation and splenocyte apoptosis. Splenectomy diminished the anti-inflammatory effects of miR-146a. The collective results support the conclusion that the induction of miR-146a expression in splenic macrophages prevents excessive inflammation and sepsis-induced multiple organ injury. This study establishes a novel and critical pathophysiological role for splenic macrophage interference in sepsis-related organ injury.
AuthorsYoshio Funahashi, Noritoshi Kato, Tomohiro Masuda, Fumitoshi Nishio, Hiroki Kitai, Takuji Ishimoto, Tomoki Kosugi, Naotake Tsuboi, Naoyuki Matsuda, Shoichi Maruyama, Kenji Kadomatsu
JournalLaboratory investigation; a journal of technical methods and pathology (Lab Invest) Vol. 99 Issue 8 Pg. 1130-1142 (07 2019) ISSN: 1530-0307 [Electronic] United States
PMID30700845 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MicroRNAs
  • Mirn146 microRNA, mouse
Topics
  • Animals
  • Disease Models, Animal
  • Macrophages (drug effects, metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs (genetics, pharmacology)
  • Multiple Organ Failure (prevention & control)
  • Plasmids (genetics)
  • RAW 264.7 Cells
  • Sepsis (prevention & control)
  • Spleen (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: